DexCom, Inc. (DXCM) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Earnings Reports
-
DexCom (DXCM) Q2 2026: Gross Margin Jumps 400bps as 15-Day G7 Rollout Accelerates
July 31, 2026
-
Dexcom (DXCM) Q4 2025: G7 15-Day Rollout Drives 200bps Margin Expansion, Unlocking Global Growth Levers
June 15, 2026
-
Dexcom (DXCM) Q1 2026: International Revenue Jumps 26% as Coverage Expansion Drives Durable Growth
May 01, 2026
-
Dexcom (DXCM) Q3 2025: 22% Revenue Growth Anchored by Type 2 Expansion and 15-Day Sensor Launch
October 31, 2025
-
Dexcom (DXCM) Q2 2025: Type 2 Non-Insulin Coverage Expands to 6M Lives, Unlocking New Growth Vector
July 30, 2025
-
Dexcom (DXCM) Q1 2025: Type 2 New Patient Uptake Hits Record, Bolstering 14% Organic Growth Trajectory
July 04, 2025